Nuveen Asset Management, LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 138,380 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

138,380

Previous 208,095 33.5%

Holding current value

Previous $8.8 Million 35.68%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$38.96 - $42.75 $2.72 Million - $2.98 Million	-69,715 Reduced 33.5%	138,380 $5.66 Million
Q1 2024 May 13, 2024	SELL	$40.88 - $43.27 $97,539 - $103,242	-2,386 Reduced 1.13%	208,095 $8.8 Million
Q4 2023 Feb 14, 2024	BUY	$20.27 - $42.44 $1.25 Million - $2.63 Million	61,871 Added 41.63%	210,481 $8.92 Million
Q3 2023 Nov 14, 2023	SELL	$20.26 - $31.91 $22,407 - $35,292	-1,106 Reduced 0.74%	148,610 $3.24 Million
Q2 2023 Aug 14, 2023	BUY	$23.9 - $35.38 $162,759 - $240,937	6,810 Added 4.77%	149,716 $4.76 Million
Q1 2023 May 15, 2023	SELL	$22.82 - $35.32 $69,874 - $108,149	-3,062 Reduced 2.1%	142,906 $3.49 Million
Q4 2022 Feb 14, 2023	SELL	$25.35 - $31.96 $87,280 - $110,038	-3,443 Reduced 2.3%	145,968 $4.6 Million
Q3 2022 Nov 14, 2022	SELL	$25.5 - $41.42 $1.77 Million - $2.87 Million	-69,334 Reduced 31.7%	149,411 $4.22 Million
Q2 2022 Aug 15, 2022	BUY	$20.62 - $37.15 $983,367 - $1.77 Million	47,690 Added 27.88%	218,745 $5.78 Million
Q1 2022 May 16, 2022	BUY	$23.5 - $35.38 $78,889 - $118,770	3,357 Added 2.0%	171,055 $5.3 Million
Q4 2021 Feb 14, 2022	SELL	$29.21 - $44.64 $826,204 - $1.26 Million	-28,285 Reduced 14.43%	167,698 $5.44 Million
Q3 2021 Nov 12, 2021	BUY	$21.26 - $38.85 $985,018 - $1.8 Million	46,332 Added 30.96%	195,983 $5.78 Million
Q2 2021 Aug 16, 2021	BUY	$12.56 - $29.69 $1.88 Million - $4.44 Million	149,651 New	149,651 $3.83 Million

Others Institutions Holding CERE

# of Institutions

270

Shares Held

155M

Call Options Held

2.19M

Put Options Held

3.92M

View Full List

About Cerevel Therapeutics Holdings, Inc.

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

More about CERE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Cerevel Therapeutics Holdings, Inc. Transaction History